MYC and Miyoshi myopathy: OTX015 was also evaluated in a cohort of 45 patients with lymphoma (n = 33) and MM (n = 12), with three DLBCL patients achieving complete remission lasting between 4 and 13 months, although no association between MYC expression levels and OTX015 sensitivity could be identified (NCT01713582) [97].